20-day net buying
+NT$6,463M
Net buying / turnover
+3.9%
Share bought
55%
vs. market
+8.7pp
60-day total
-2.7%
Net buying / turnover
Over the last 20 trading days, what institutions bought minus what they sold, as a share of this industry's total trading value over the same period.
+3.9% Latest 2026-11-17
Share bought
Share of companies with net buying over the last 20 days. The largest company can't skew it.
55% Latest 2026-11-17
86 bought, 70 sold
vs. market
Against the market average, whether institutions are buying this industry more (positive) or less (negative).
+8.7pp Latest 2026-11-17
Companies
| # | Ticker | Name | 20-day turnover | Net buying | Share of turnover | Contribution (pp) |
|---|---|---|---|---|---|---|
| 1 | 6446 | PEC | NT$84,468M | +NT$2,739M | +3.2% | +1.7 |
| 2 | 6472 | Bora | NT$7,037M | +NT$727.4M | +10.3% | +0.4 |
| 3 | 6491 | PEGAVISION | NT$2,902M | +NT$393.9M | +13.6% | +0.2 |
| 4 | 6467 | TAHO Pharma | NT$4,241M | +NT$393.8M | +9.3% | +0.2 |
| 5 | 6919 | Caliway | NT$9,797M | +NT$305.5M | +3.1% | +0.2 |
| 6 | 7799 | HNMC | NT$4,471M | +NT$273.9M | +6.1% | +0.2 |
| 7 | 4105 | TTY | NT$1,350M | +NT$218.4M | +16.2% | +0.1 |
| 8 | 6782 | VISCO | NT$3,271M | +NT$201.0M | +6.1% | +0.1 |
| 9 | 4743 | ONENESS BIOTECH | NT$1,576M | +NT$194.1M | +12.3% | +0.1 |
| 10 | 1795 | Lotus Pharm | NT$5,812M | +NT$189.2M | +3.3% | +0.1 |
| 11 | 4147 | TMB | NT$1,077M | +NT$185.2M | +17.2% | +0.1 |
| 12 | 6589 | EirGenix | NT$862.1M | +NT$175.7M | +20.4% | +0.1 |
| 13 | 6949 | PELL BMT | NT$4,608M | +NT$157.8M | +3.4% | +0.1 |
| 14 | 6617 | Gongwin | NT$1,391M | +NT$142.1M | +10.2% | +0.1 |
| 15 | 6861 | INCX | NT$2,368M | +NT$90.9M | +3.8% | +0.1 |